Furthermore, we are aware of only a few studies analysing urinary KP metabolites as a diagnostic biomarker in conditions such as attention-deficit hyperactivity disorder (43), cardiovascular events (44), heart failure (45), and breast cancer (46). The gene discussed is NPPA; the disease is breast carcinoma.